APPLICATION
ANDA208347
TYPE
ANDA
ORIGINAL APPROVAL
2018-02-20
LATEST ACTION
2021-07-22
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
OSELTAMIVIR PHOSPHATEPrescription
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML · FOR SUSPENSION · ORAL
Approval history
2021-07-22Labeling · Supplement 6 · standardAP
2019-12-20Labeling · Supplement 5 · standardAP
2019-12-20Labeling · Supplement 1 · standardAP
2019-12-20Labeling · Supplement 4 · standardAP
2018-02-20UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.